Versant Vantage I, L.P. (CIK 1765253) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-09-23). Recent activity: Sell LVTX (2.4M shares), Sell LVTX (532,870 shares), Sell LVTX (307,707 shares), Sell LVTX (192,293 shares), Sell LVTX (362,806 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-09-23 | LAVA Therapeutics NV (LVTX) | Insider | Sell | 2.4M | $3.3M |
| 2025-09-23 | LAVA Therapeutics NV (LVTX) | Insider | Sell | 532,870 | $746,018 |
| 2025-09-18 | LAVA Therapeutics NV (LVTX) | Insider | Sell | 307,707 | $470,792 |
| 2025-09-18 | LAVA Therapeutics NV (LVTX) | Insider | Sell | 192,293 | $294,208 |
| 2025-09-18 | LAVA Therapeutics NV (LVTX) | Insider | Sell | 362,806 | $540,581 |
| 2025-09-18 | LAVA Therapeutics NV (LVTX) | Insider | Sell | 226,726 | $337,822 |
| 2025-09-18 | LAVA Therapeutics NV (LVTX) | Insider | Sell | 366,111 | $527,200 |
| 2025-09-18 | LAVA Therapeutics NV (LVTX) | Insider | Sell | 228,791 | $329,459 |
Source: SEC Form 4 filings · as of 2025-09-23